NeuroMetrix Company
NeuroMetrix is a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes. The Company currently markets products for the detection, diagnosis, and monitoring of diabetic neuropathies such as diabetic peripheral neuropathy and median neuropathy (carpal tunnel syndrome).
Technology:
NeuroMonitoring / Imaging
Industry:
Biomarkers for Longevity
Headquarters:
Waltham, Massachusetts, United States
Zip:
101-250
Founded Date:
1996-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
105180003
Total Funding:
$1M to $10M
Estimated Revenue:
2004-07-22
Last Funding Date:
Post-IPO Equity
Last Funding Type:
info@neurometrix.com
Register and Claim Ownership